MKI67 and cancer: As shown in the lower panel of Figure 4G, a remarkable reduction in the cell proliferation marker (Ki67) was seen upon targeting of the CAFs alone and this was further suppressed when both bispecific adapters were administered, i.e. confirming that CAFs indeed contribute to cancer cell proliferation and that dual targeting of both CAFs and cancer cells is more effective than targeting either cell type alone.